Simulations Plus (SLP) Announces Collaboration Agreement with Top-5 Pharma Company
Simulations Plus, Inc. (Nasdaq: SLP) announced today that it has signed a collaboration agreement with a top-5 pharmaceutical company to extend and enhance its oral cavity dosing model within its industry gold standard GastroPlus™ simulation software program.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Caesars Entertainment (CZR) Loses Another Bid to Stop Bondholder Litigation - Bloomberg
- Genie Energy (GNE) Unit Afek Affirms Significant Gas Quantities Within Exploratory Area
- Applied DNA Sciences (APDN) Issues Positive Update on SigNature T DNA Shipments for Cotton Tagging
Create E-mail Alert Related CategoriesCorporate News
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!